These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2690835)

  • 1. [Is fibrocystic disease precancerous?].
    De León Antoni E
    Bol Asoc Med P R; 1989 Nov; 81(11):451-4. PubMed ID: 2690835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is 'fibrocystic disease' of the breast precancerous? A consensus report from the College of American Pathologists.
    Indiana Med; 1986 Sep; 79(9):753-4. PubMed ID: 3772069
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is 'fibrocystic disease' of the breast precancerous?
    Arch Pathol Lab Med; 1986 Mar; 110(3):171-3. PubMed ID: 3606334
    [No Abstract]   [Full Text] [Related]  

  • 6. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of proliferative breast lesions around breast cancers].
    Moriya T; Manabe T; Sakurai T; Sakamoto K
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():42-5. PubMed ID: 7747991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors.
    Petrakis NL; Ernster VL; King EB; Sacks ST
    J Natl Cancer Inst; 1982 Jan; 68(1):9-13. PubMed ID: 6948129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypia in the assessment of breast cancer risk: implications for management.
    Vogel VG
    Diagn Cytopathol; 2004 Mar; 30(3):151-7. PubMed ID: 14986294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histology, normal borderline forms and pathologic proliferation patterns of the breast].
    Holzner JH
    Verh Dtsch Ges Pathol; 1985; 69():26-50. PubMed ID: 4096107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign breast disease and the risk of breast cancer in the next 15 years.
    Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is fibrocystic disease of the breast precancerous?
    Godfrey SE
    Arch Pathol Lab Med; 1986 Nov; 110(11):991. PubMed ID: 3778132
    [No Abstract]   [Full Text] [Related]  

  • 19. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathology, systematic aspects and classification of benign breast diseases].
    Bässler R; Kind M
    Gynakologe; 1989 Aug; 22(4):216-25. PubMed ID: 2676756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.